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ABSTRACT 
Aims: Aflatoxin B1 (AFB1) is considered as the most toxic food contaminant, and 
microorganisms, especially bacteria, have been studied for their potential to reduce the 
bioavailability of mycotoxins including aflatoxins. Therefore, this research investigated the 
efficacy of oral administration of Lactobacillus casei Shirota (LcS) in aflatoxin-induced rats. 
Methods and Results: Sprague Dawley rats were divided into three groups of untreated 
control, the group induced with AFB1 only, and the group given probiotic in addition to 
AFB1. In the group induced with AFB1 only, food intake and body weight were reduced 
significantly. The liver and kidney enzymes were significantly enhanced in both groups 
induced with AFB1, but they were lower in the group given LcS. AFB1 was detected from all 
serum samples except for untreated control group's samples. Blood serum level of AFB1 in 
the group induced with AFB1 only was significantly higher than the group which received 
probiotic as a treatment (P < 0·05), and there was no significant difference between the 
control group and the group treated with probiotic. Conclusions: LcS supplementation could 
improve the adverse effect of AFB1 induction on rats' body weight, plasma biochemical 
parameters and also could reduce the level of AFB1 in blood serum. Significance and Impact 
of the Study: This study's outcomes contribute to better understanding of the potential of 
probiotic to reduce the bioavailability ofAFB1. Moreover, it can open an opportunity for 
future investigations to study the efficacy of oral supplementation of probiotic LcS in 
reducing aflatoxin level in human. 
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